vs
ARROWHEAD PHARMACEUTICALS, INC.（ARWR）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是ARROWHEAD PHARMACEUTICALS, INC.的1.2倍（$324.4M vs $264.0M），ARROWHEAD PHARMACEUTICALS, INC.净利率更高（11.7% vs 5.7%，领先6.0%），ARROWHEAD PHARMACEUTICALS, INC.同比增速更快（10461.3% vs 10.4%），ARROWHEAD PHARMACEUTICALS, INC.自由现金流更多（$11.3M vs $-13.3M）
Arrowhead Pharmaceuticals是总部位于美国加利福尼亚州帕萨迪纳的上市生物制药企业，专注于通过RNA干扰（RNAi）作用机制开发创新药物，核心研发管线覆盖乙型肝炎、α-1抗胰蛋白酶缺陷相关肝病及心血管疾病的治疗领域。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
ARWR vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.2倍
$264.0M
营收增速更快
ARWR
高出10450.9%
10.4%
净利率更高
ARWR
高出6.0%
5.7%
自由现金流更多
ARWR
多$24.6M
$-13.3M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $264.0M | $324.4M |
| 净利润 | $30.8M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | 15.5% | 6.3% |
| 净利率 | 11.7% | 5.7% |
| 营收同比 | 10461.3% | 10.4% |
| 净利润同比 | 117.8% | 50.4% |
| 每股收益（稀释后） | $0.22 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARWRRVLV
| Q4 25 | $264.0M | $324.4M | ||
| Q3 25 | — | $295.6M | ||
| Q2 25 | — | $309.0M | ||
| Q1 25 | — | $296.7M | ||
| Q4 24 | — | $293.7M | ||
| Q3 24 | — | $283.1M | ||
| Q2 24 | — | $282.5M | ||
| Q1 24 | — | $270.6M |
净利润ARWRRVLV
| Q4 25 | $30.8M | $18.6M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $10.9M |
毛利率ARWRRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率ARWRRVLV
| Q4 25 | 15.5% | 6.3% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | 3.4% |
净利率ARWRRVLV
| Q4 25 | 11.7% | 5.7% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）ARWRRVLV
| Q4 25 | $0.22 | $0.27 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $715.0M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $568.4M | $512.5M |
| 总资产 | $1.6B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARWRRVLV
| Q4 25 | $715.0M | $292.3M | ||
| Q3 25 | — | $315.4M | ||
| Q2 25 | — | $310.7M | ||
| Q1 25 | — | $300.8M | ||
| Q4 24 | — | $256.6M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | — | $244.7M | ||
| Q1 24 | — | $273.4M |
股东权益ARWRRVLV
| Q4 25 | $568.4M | $512.5M | ||
| Q3 25 | — | $490.2M | ||
| Q2 25 | — | $468.6M | ||
| Q1 25 | — | $453.4M | ||
| Q4 24 | — | $437.8M | ||
| Q3 24 | — | $420.8M | ||
| Q2 24 | — | $405.8M | ||
| Q1 24 | — | $389.9M |
总资产ARWRRVLV
| Q4 25 | $1.6B | $765.0M | ||
| Q3 25 | — | $751.3M | ||
| Q2 25 | — | $722.9M | ||
| Q1 25 | — | $713.9M | ||
| Q4 24 | — | $665.5M | ||
| Q3 24 | — | $670.9M | ||
| Q2 24 | — | $657.8M | ||
| Q1 24 | — | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.5M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $11.3M | $-13.3M |
| 自由现金流率自由现金流/营收 | 4.3% | -4.1% |
| 资本支出强度资本支出/营收 | 0.8% | 1.0% |
| 现金转化率经营现金流/净利润 | 0.44× | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流ARWRRVLV
| Q4 25 | $13.5M | $-10.2M | ||
| Q3 25 | — | $11.8M | ||
| Q2 25 | — | $12.6M | ||
| Q1 25 | — | $45.1M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $-24.7M | ||
| Q1 24 | — | $38.4M |
自由现金流ARWRRVLV
| Q4 25 | $11.3M | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
自由现金流率ARWRRVLV
| Q4 25 | 4.3% | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度ARWRRVLV
| Q4 25 | 0.8% | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率ARWRRVLV
| Q4 25 | 0.44× | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARWR
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
